中国对虾某些免疫指标的测定及免疫预防初步研究

通过口服免疫药物后，对虾血清中溶菌酶、酚氧化酶（ＰＯ）活力及免疫保护率测定，来作为衡量对虾免疫状态的指标，并用弧菌疫苗浸泡法及口服免疫药物，提高虾体自身免疫能力，增强疾病抵抗力．     

A Review on Salivary Genomics and Proteomics Biomarkers in Oral Cancer

Oral cancer has emerged as an alarming public health problem with increasing incidence and mortality rates all over the world. Therefore, the implementation of newer screening and early detection approaches are of utmost importance which could reduce the morbidity and mortality associated with this disease. Sensitive and specific biomarkers for oral cancer are likely to be most effective for screening, diagnosis, staging and follow-up for this dreaded malignancy. Unlike other deep cancers, oral cancer is located in oral cavity. Hence, the direct contact between saliva and oral cancer lesion makes the measurement of tumor markers in saliva an attractive alternative to serum and tissue testing. The DNA, RNA and protein molecules derived from the living cancer cells can be conveniently obtained from saliva. Thus, salivary biomarkers, a non-invasive alternative to serum and tissue-based biomarkers may be an effective modality for early diagnosis, prognostication and monitoring post therapy status. In the current post-genomic era, various technologies provide opportunities for high-throughput approaches to genomics and proteomics; which have been used to evaluate altered expressions of gene and protein targets in saliva of oral cancer patients. The emerging field of salivary biomarkers has great potentials to prove its clinical significance to combat oral cancer. Hence, we have reviewed importance of several salivary genomics and proteomics biomarkers for oral cancer.     

身体活动降低罹患乳腺癌风险的生物学机制研究进展

乳腺癌是目前我国发病率较高的癌症类型,直接关系到众多女性的健康.科学预防乳腺癌的发生是控制乳腺癌发病率的重要途径.已有的流行病学研究证明,身体活动可以显著降低罹患乳腺癌的风险.通过综合近年来国际主流文献对身体活动干预乳腺癌发生的机制研究,阐述身体活动干预乳腺癌的可能的生物学途径,尤其是对乳腺癌生物标记物的干预效果,这些生物指标主要包括身体质量指数、雌/雄激素、胰岛素耐受、脂肪因子以及TNF-a、Ⅱ-6等炎症因子.女性长期进行中等强度以上的锻炼,可以通过控制体重、减少脂肪、降低循环雌激素水平、改善胰岛素耐受、调控脂肪因子以及拮抗炎症因子等生物学途径预防乳腺癌的发生.由于雌激素代谢、胰岛素敏感性、脂肪因子合成等均与脂肪组织有关,因此,通过身体活动控制体重是预防乳腺癌的核心.建议重视长期跟踪实验及对多种人群的干预研究;在实验中需对身体活动的类型及运动强度、持续时间等进行详细阐述,进一步改进评估方法.     

泰州市海陵区2012年疑似接种异常反应分析

目的：分析泰州市海陵区2012年疑似预防接种异常反应,以进一步规范预防接种行为。方法对疑似预防接种异常反应信息管理系统中2012年泰州市海陵区发生的所有AEFI 病例进行 Excel 分析。结果2012年海陵区报告 AEFI 病例89例,发生率为8.11/万,7价肺炎疫苗、 HIB 疫苗、白破疫苗发生率位于前3位;副反应主要为局部反应,病例预后良好。结论泰州市海陵区2012年 AEFI 与接种疫苗品种、接种人群年龄与接种时间可能有关,7价肺炎疫苗、 HIB 疫苗与白破疫苗,是引起 AEFI 的主要疫苗;婴幼儿（〈2岁）是高发人群,接种疫苗后1天内是好发时间。     

大学生和中学生对肿瘤早期检查认知状况的比较分析

目的:对比分析大中学生对肿瘤早期检查的认知和需求。方法:选取金华市1所中学和1所大学学生共568名进行调查与分析。结果:中学生对肿瘤相关的健康生活方式水平认知程度比大学生的认知程度低,中学生在对肿瘤可防可治和肿瘤早期筛查项目的认识程度低,大学生对肿瘤早期检查的态度比中学生更积极。结论:大中学生对肿瘤早期检查的认知程度较低,有关学校尤其是中学应重视开展肿瘤早期发现的健康教育工作。     

静默疗法对肿瘤化疗病人恶心、呕吐的防治作用

目的探索静默疗法对肿瘤化疗副反应的作用。方法将300例进行化学治疗的肿瘤病人随机分为对照组和试验组,每组各150例病人。对照组进行治疗时,只用常规的恩丹西酮预防恶心、呕吐等副作用;而试验组除了用恩丹西酮外,在受过专门训练护理人员的指导下用静默疗法辅助治疗来预防恶心、呕吐等副作用。结果试验组胃肠道等副反应控制率为57%,与对照组(43%)比较,有显著性差异(P<0.05)。结论静默疗法有减轻或防止化疗药物引起的胃肠道反应等副反应的作用。     

A Comparative Study of Bone Scan Findings and Serum Levels of Tumor Marker CA15-3 in Patients with Breast Carcinoma

Breast cancer is one of the most frequent malignancies in the world. Available staging procedures to detect breast cancer are bone scan, chest X-ray, liver ultrasonography, computerized tomography, estimation of tumor markers like carbohydrate antigen (CA15-3) and carcino embryonic antigen. These procedures are expensive and may not be required in all cases. Out of 70 patients studied, 55 had normal CA15-3 and 15 had elevated levels of Ca15-3. Eight (14.5%) of the 55 patients with normal CA15-3 had abnormal bone scan. Fifteen patients had CA15-3 levels above the normal range and among these 9 (60%) had abnormal bone scan. While prime facie it would appear that a high level of CA15-3 correlate with abnormal bone scan, it is also true that the numbers are small at present and conclusions about the validity of CA15-3 as marker of bone metastasis may be premature.     

氯化铵对顺铂诱导A549细胞凋亡的形态学研究

目的探讨氯化铵(NH4CL)对顺铂(cisplatin,CDDP)抑制A549细胞增殖的影响。方法体外培养人肺癌A549细胞,MTT法检测NH4CL及CDDP对人肺癌A549细胞增殖率的影响;光镜下观察NH4CL及CDDP对A549细胞生长的影响;共聚焦显微镜下观察A549细胞核的形态变化。结果与对照组相比,给予不同浓度的NH4CL及CDDP导致A549细胞增殖率明显下降;光镜下观察A549细胞经非毒性剂量的NH4CL与CDDP联合应用处理后细胞生长抑制明显高于单独给予CDDP组;共聚焦显微镜观察可见非毒性剂量的NH4CL与CDDP联合应用处理A549细胞核碎裂现象明显多于单独CDDP处理组。结论 NH4CL可以促进CDDP对A549A细胞的凋亡诱导作用。     

分段逆向调强优化方法在乳腺癌调强放疗计划设计中的应用研究

目的:制作乳腺癌调强放疗计划时,采用分段逆向调强优化方法以达到更好的靶区剂量和保护肺、心脏等危及器官。方法:应用Eclipse8.6计划系统针对10例乳腺癌患者(肿瘤原发部位左右侧各5例)分别制定T1,T2模式调强放疗计划,处方剂量均为DT50Gy/25次。T1模式采用左乳300°、330°、0°、30°、60°、90°和120°方向射野,右乳60°、30°、0°、330°、300°、270°和240°方向射野,设置优化参数进行逆向优化和剂量运算。T2模式采用与T1模式相同的角度方向设野,第一段总剂量24Gy,分次剂量2Gy,分12次治疗,设置优化参数进行逆向优化和剂量运算;第二段总剂量26Gy,分次剂量2Gy,分13次照射,设置优化参数,采用"Base dose plan"功能选择基于第一段治疗计划以总量50Gy来逆向优化和剂量运算。将两段计划相加作为T2模式的治疗计划,通过剂量体积直方图比较两种模式下计划的靶体积和危及器官剂量分布。结果:T1、T2模式调强放疗计划的靶体积均满足临床剂量要求,对于左侧乳腺癌,适形指数分别为0.727±0.034、0.751±0.034(t=-6.20,P=0.003);对于右侧乳腺癌,适形指数分别为0.691±0.058、0.729±0.048(t=-5.39,P=0.006)。对左侧乳腺癌,T2模式的左肺V10(%)、左肺V20(%)、左肺V30(%)、全肺V10(%)、全肺V20(%)、全肺V30(%)和心脏V10(%)均大于T1模式,分别增大5.0%、2.7%、3.7%、4.6%、2.6%、3.8%和4.4%。对于右侧乳腺癌,无充分证据说明危及器官各指标有差别。结论:与T1模式相比,采用分段逆向调强优化方法能更好的优化靶区的剂量分布,但对左侧乳腺癌而言,会略微增加左肺、全肺和心脏剂量受量。     

Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients

Objective  

The purpose of this study was to determine the unique and universal features of microsatellite instability-high (MSI-H) colorectal cancer (CRC) and MSI-H gastric cancer (GC) in the Chinese population.